The antivenin market for treating bites from rattlesnakes and other pit vipers might be considered a case study of why drugs prices are so high. Head-to-head competition between brand-name medicines may not meaningfully reduce prices.

In by

The antivenin market for treating bites from rattlesnakes and other pit vipers might be considered a case study of why drugs prices are so high. Head-to-head competition between brand-name medicines may not meaningfully reduce pric